David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
PUT
Wolfspeed
WOLF
$1.29B
| $291K | ﹤0.01% |
10,000
-122,300
| -92% | -$3.5M |
|
|
ARAV
3002
DELISTED
Aravive, Inc. Common Stock
ARAV
| $290K | ﹤0.01% |
+6,036
| New | +$320K |
|
3003
Regency Centers
REG
$14B
| $289K | ﹤0.01% |
3,865
-3,544
| -48% | -$253K |
|
3004
PUT
Tenet Healthcare
THC
$22.4B
| $289K | ﹤0.01% |
10,000
-7,700
| -44% | -$200K |
|
|
SSE
3005
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $289K | ﹤0.01% |
498,472
+229,303
| +85% | +$129K |
|
3006
PUT
Credicorp
BAP
$30.2B
| $288K | ﹤0.01% |
2,200
-10,000
| -82% | -$1.1M |
|
|
FRGI
3007
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $288K | ﹤0.01% |
8,800
+567
| +7% | +$20K |
|
3008
Federal Realty Investment Trust
FRT
$10.2B
| $286K | ﹤0.01% |
1,835
| – | – |
|
|
WCN
3009
Waste Connections
WCN
$42.5B
| $286K | ﹤0.01% |
6,641
-173,829
| -96% | -$7M |
|
3010
PUT
WisdomTree
WT
$3.61B
| $286K | ﹤0.01% |
+25,000
| New | +$300K |
|
3011
Ross Stores
ROST
$77.5B
| $285K | ﹤0.01% |
4,923
-10,694
| -68% | -$594K |
|
|
VSI
3012
DELISTED
Vitamin Shoppe Inc.
VSI
| $285K | ﹤0.01% |
9,198
+1,059
| +13% | +$31.8K |
|
3013
Capital Southwest
CSWC
$1.61B
| $284K | ﹤0.01% |
20,452
+230
| +1% | +$3.23K |
|
3014
BGC Group
BGC
$5.68B
| $283K | ﹤0.01% |
48,623
-52,553
| -52% | -$302K |
|
|
PFC
3015
DELISTED
Premier Financial Corp. Common Stock
PFC
| $283K | ﹤0.01% |
14,722
-5,730
| -28% | -$110K |
|
|
CTRL
3016
DELISTED
Control4 Corporation
CTRL
| $283K | ﹤0.01% |
+35,563
| New | +$264K |
|
|
NFBK
3017
DELISTED
Northfield Bancorp
NFBK
| $281K | ﹤0.01% |
17,118
-162
| -0.9% | -$2.52K |
|
3018
First Financial Corp
THFF
$947M
| $281K | ﹤0.01% |
8,209
+1,748
| +27% | +$57.7K |
|
|
RXII
3019
DELISTED
GALENA BIOPHARMA INC COM
RXII
| $281K | ﹤0.01% |
206,943
+146,141
| +240% | +$198K |
|
|
MPT
3020
Medical Properties Trust
MPT
$2.46B
| $280K | ﹤0.01% |
21,543
-550
| -2% | -$6.27K |
|
3021
Teledyne Technologies
TDY
$29B
| $280K | ﹤0.01% |
3,179
+280
| +10% | +$23.3K |
|
|
BUFF
3022
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $280K | ﹤0.01% |
+10,901
| New | +$209K |
|
|
CACB
3023
DELISTED
Cascade Bancorp
CACB
| $280K | ﹤0.01% |
49,082
-12,475
| -20% | -$68.4K |
|
|
BHR
3024
Braemar Hotels & Resorts
BHR
$141M
| $277K | ﹤0.01% |
23,951
-2,003
| -8% | -$21.3K |
|
3025
Colliers International
CIGI
$5.51B
| $277K | ﹤0.01% |
7,300
-6,200
| -46% | -$228K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.